United States Federal Circuit
University of Utah Research v. Ambry Genetics, 14-1361
In this patent litigation, plaintiff Myriad, owner of the '441, '282, and '492 patents which cover compositions of matter and methods relating to the BRCA1 and BRCA2 genes, seeks to enjoin the alleged infringement of six claims of their three patents. Denial of Myriad's motion for preliminary injunction is affirmed, where the claims are directed to patent-ineligible subject matter in violation of 35 U.S.C. section 101.
Appellate Information
- Decided 12/17/2014
- Published 12/17/2014
Judges
- Dyk
Court
- United States Federal Circuit